EPG Online Twitter
EPG Online Blog
Disease Knowledge
Drug Updates
Yutopar Tablets: Follow-on to Yutopar
Tablets: Follow-on to parenteral therapy to maintain uterine quiescence.
Yutopar: Uncomplicated preterm labour between 24 - 33 weeks gestation. To delay delivery to enable glucocorticosteroids or other measures to be used.
- Fostair 100/6 inhalation solution
- Epanutin capsules 25, 50 and 100mg
- Eprex 2000, 4000 and 10000 IU/ml solution for injection in pre-filled syringe
- FemSeven Conti
- Epanutin 300mg hard capsules
- Bedranol 80mg SR Capsules
- Bedranol 160mg SR Capsules
- Betim 10mg Tablets
- Carbo-Dome Cream
- Bisoprolol 2.5mg/5mg/10mg film coated tablet
- Phenergan Injection
- Rivotril 0.5 mg and 2 mgTablets
- Rivotril Ampoules
- RELPAX 20mg and 40mg Film-Coated Tablets
- Witch Doctor ® 81.5%w/w Gel
- Levetiracetam Actavis 1,000 mg film-coated tablets
- Levetiracetam Actavis 250 mg film-coated tablets
- Levetiracetam Actavis 500 mg film-coated tablets
- Levetiracetam Actavis 750 mg film-coated tablets
- Lidocaine Hydrochloride Injection BP 1% w/v plastic ampoules
- Lidocaine Hydrochloride Injection BP 2.0% w/v
- Omeprazole 10mg Capsules
- Omeprazole 20mg Capsules
- Panadol Extra Advance 500 mg/65 mg Tablets
- Allopurinol Tablets BP 300mg
- Allopurinol Tablets BP 100mg
- Anadin Ultra Double Strength 400mg Capsules/Anadin LiquiFast 400mg Capsules
- Calcipotriol Scalp Solution
- Bupivacaine Hydrochloride Injection BP 0.5% w/v.
- Lescol (fluvastatin* sodium) 20 mg and 40 mg capsules
- Meropenem 1 g Powder for Solution for Injection or Infusion
- VALTREX Tablets 250mg
- Vesicare 5mg & 10mg film-coated tablets
- Zomig 5mg Nasal Spray
- Water for Injections
- Tizanidine 2mg Tablets
- NovoRapid 100 U/ml in a vial, NovoRapid Penfill 100 U/ml, NovoRapid FlexPen 100 U/ml, NovoRapid FlexTouch 100 U/ml
- Orfadin 10 mg hard capsules
- Orfadin 2 mg hard capsules
- Natecal D3 Chewable Tablets
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
b-agonists (beta-agonists, beta- adrenoceptor stimulants).
Ritodrine
Yutopar Tablets: yellow, scored tablet marked YUTOPAR. Yutopar: ampoule.
Yutopar Tablets: Ritodrine hydrochloride 10 mg . Yutopar: Ritodrine hydrochloride 10 mg /mL.
Yutopar Tablets: Follow-on to Yutopar
Tablets: Follow-on to parenteral therapy to maintain uterine quiescence.
Yutopar: Uncomplicated preterm labour between 24 - 33 weeks gestation. To delay delivery to enable glucocorticosteroids or other measures to be used.
Yutopar Tablets: 1 approximately 30 minutes before termination of intravenous therapy. Maintenance: 1 two hourly for 24 hours, then 1 or 2 four to six hourly.
Yutopar: Initially 50 microgram/ minute intravenously in 5% dextrose solution, increase gradually until control. Usual range, 150 - 350 microgram/ minute. Continue infusion for 12 - 48 hours after contractions have stopped. Use a syringe pump to reduce fluid overload.
Not applicable.
Antepartum haemorrhage, eclampsia, pre-eclampsia, cord compression, foetal death, chorioamnionitis, maternal cardiac disease.
Avoid fluid overload; keep intravenous fluids to minimum and monitor maternal hydration. Multiple pregnancy, suspected cardiovascular disease, maternal infection, hyperthyroidism, hypertension, diabetes. Monitor maternal and foetal heart rate.
MAOIs, tricyclic antidepressants, corticosteroids, sympathomimetics, anaesthetics, K+-depleting diuretics, b- blockers.
Maternal pulmonary oedema (withdraw drug immediately and institute diuretic therapy). Tachycardia, flushing, sweating, nausea, chest pain, arrhythmia, vomiting, rise in blood sugar, tremor, leucopenia and/or agranulocytosis, impaired liver function, raised liver transaminases, enlarged salivary glands, increased amylase
Solvay
(POM)
17 June 2009





